Viewing nowCombinationTruStar Tablet 80/5 mg
Telmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201505199 · Approved 2015.07.31 · Insurance code 650303420
Treatment of hypertension and dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is used for patients who need to take two medications, telmisartan and rosuvastatin, simultaneously. Telmisartan is primarily administered to patients with essential hypertension or those at high risk of cardiovascular diseases such as myocardial infarction or stroke. It is particularly effective in high-risk diabetic patients who cannot use ACE inhibitors. Meanwhile, rosuvastatin helps manage hypercholesterolemia and combined hyperlipidemia and is used as an adjunct when diet alone does not control the condition. Furthermore, it contributes to reducing the risk of cardiovascular diseases, including stroke and myocardial infarction, and reduces risks after vascular revascularization. By administering both medications together, it effectively manages cardiovascular health by improving hypertension and dyslipidemia simultaneously.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams per day. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration.
This medication can cause severe harm to the fetus and newborn during pregnancy; thus, it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication, pregnant, or breastfeeding women, and fertile women who do not use adequate contraceptive methods should not take it. Patients with severely impaired liver function or those with biliary excretion issues, and patients with muscle diseases should use caution when administering this medication. Patients with very poor renal function or those taking certain immunosuppressants, as well as diabetic patients with decreased renal function, should ideally not use this medication. Since this medication contains lactose, patients with lactose intolerance or specific genetic metabolic disorders should not take it. Elderly patients, patients with elevated serum potassium levels, and patients with slightly impaired liver function should use this medication carefully, and liver and muscle function tests should be performed regularly. If muscle-related symptoms such as myalgia, muscle weakness, or muscle cramps occur, consult a physician immediately, and discontinue use if necessary. This medication may interact with other antihypertensive agents or lipid-lowering agents, so you should inform your physician about any other medications you are taking. During treatment with this medication, abnormalities in liver function, blood pressure decreases, allergic reactions, or angioedema may occur, so symptoms should be reported to healthcare professionals immediately. Be cautious as dizziness or drowsiness may occur while driving or operating dangerous machinery.
Headache, orthostatic dizziness, sleep paralysis, increased blood pressure, decreased blood pressure, hypotension, elevated ALT, dysuria, rhinitis, discomfort in the oropharynx, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, hepatic dysfunction, liver impairment, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute kidney failure, chest pain, fatigue, influenza-like illness, increased blood creatinine, elevated blood uric acid, increased liver enzymes, elevated blood CK, decreased hemoglobin, hypoglycemia, angioedema, hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom-associated drug reaction syndrome, lupus-like syndrome, muscle tear, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, severe muscle weakness, ocular myasthenia, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, appetite loss, arrhythmia, weakness, edema, decreased libido, facial swelling, alopecia, conjunctivitis, tinnitus, pinpoint hemorrhages, palpitations, fatigue, nausea, lack of efficacy, edema, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute kidney failure, oliguria, thrombocytopenia, increased blood creatinine, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure, hypotension, tachycardia, bradycardia, dizziness, acute kidney failure
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain storage temperature between 1 degree and 30 degrees Celsius.
Light pink oval film-coated tablet
30 tablets (10 tablets x 3 PTP)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.